Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trial

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2025-02-26
DOI
https://doi.org/10.3389/fmed.2025.1531370
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trial

Xuhua Yu, Feiting Fan, Zhongyang Deng, Luoqi Lin et al.
Frontiers in Medicine
Long-Term Effects of COVID-19
article

Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trial

Xuhua Yu, Feiting Fan, Zhongyang Deng, Luoqi Lin, Yuewei Li, Lei Wu, Sha Jin, Ruhong Xu, Jingmin Xiao, Jingyu Quan, S. Li, Yuanbin Chen, Long Fan, Xiaochun Chen, Xinying Lin, Zhu Mengting, Y. Chi, Ziyao Liang
article en

Abstract

No abstract available for this paper.
Frontiers in MedicineVol. 12
Guangzhou University of Chinese Medicine (CN), Dongguan People’s Hospital (CN)
Openalex Percentile: Top 94%
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.